Current evidence and future directions for KIM-1 as a blood-based biomarker in RCC

Nature Reviews Clinical Oncology 2026

View at publisher

Authors: Wenxin Xu, Joseph V. Bonventre, Toni K. Choueiri

DOI: 10.1038/s41571-026-01163-w

Cited by: 1

References: 9

Fields of Study & Subjects

Galectins and Cancer Biology Acute Kidney Injury Research Angiogenesis and VEGF in Cancer

References 9